Floatz logo

Asundexian

Acute Myocardial Infarction

BayerSmall moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Acute Myocardial Infarction cohort.

Asset / SponsorPhaseRating
Sitagliptin
University of Sao Paulo General Hospital
Phase 3BB
Saxagliptin
University of Sao Paulo General Hospital
Phase 3BB
Quadrivalent Inactivated Influenza Vaccine
Kaiser Permanente
UnknownD
Flublok Quadrivalent
Kaiser Permanente
UnknownD

Same molecule, other indications

Asundexian is also rated in:

ischemic strokeActive
BB
Indicative · Phase 3
66 / 100
View asset →
transient ischemic attackActive
B
Indicative · Phase 3
62 / 100
View asset →
stroke disorderActive
B
Indicative · Phase 3
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →